New tool aims to measure Kids' GVHD symptoms more accurately
NCT ID NCT04044365
First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 5 times
Summary
This study aims to create a symptom questionnaire specifically for children and teens living with chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Current symptom scales are designed for adults, but children may describe their symptoms differently. Researchers will interview children aged 5-17 and their parents to develop and test a new scale that better captures how bothersome symptoms are, with the goal of improving care and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a better tool to understand and manage symptoms in children with chronic GVHD, improving their quality of life.
- What could go wrong
- This is an early-stage study focused on developing a questionnaire, not testing a treatment. It may not lead to direct improvements in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children s National Medical Center (CNMC)
Washington D.C., District of Columbia, 20010, United States
-
Children's & Women's Health Centre of British Columbia (CWHC of BC)
Vancouver BC, Canada
-
Children's Healthcare of Atlanta - Egleston Hospital
Atlanta, Georgia, 30322, United States
-
Children's Hospital Colorado (CHCO)
Aurora, Colorado, 80045, United States
-
Children's Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
City of Hope
Duarte, California, 91010, United States
-
Fred Hutchinson Cancer Center (FHCC)
Seattle, Washington, 98109, United States
-
Hospital for Sick Children (SickKids)
Toronto, Canada
-
Johns Hopkins Hospital (JHH)
Baltimore, Maryland, 21287, United States
-
Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
St. Jude Children s Research Hospital
Memphis, Tennessee, 38105, United States
-
Texas Children's Hospital (TCH)-Baylor
Houston, Texas, 77030, United States
-
The University of Texas MD Anderson Cancer Institute
Houston, Texas, 77030, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Pittsburgh - Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can meditation tame the Long-Term side effects of a stem cell transplant?
- Could a liquid form of a Graft-Versus-Host disease drug be as effective as the pill?
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
- Scientists map immune battlefield in chronic GVHD tissue
- Could a rheumatoid arthritis drug tame chronic GVHD and cut steroid use?
- Gene analysis may unlock secrets of bone marrow transplant complication